Memantine in Japanese patients with moderate to severe Alzheimer's disease: Meta-analysis of multiple-index responder analyses.
CONCLUSIONS: Memantine is a viable treatment option for patients with AD presenting not only with cognitive impairment, but also with a broader range of symptoms, including the behavioral and psychological symptoms of dementia.
PMID: 29448852 [PubMed - as supplied by publisher]
Source: Expert Opinion on Pharmacotherapy - Category: Drugs & Pharmacology Tags: Expert Opin Pharmacother Source Type: research
More News: Alzheimer's | Clinical Trials | Dementia | Drugs & Pharmacology | Japan Health | Namenda | Pathology | Psychology | Statistics | Study